Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Amit Bar-Or
Induction of Antigen-Specific Tolerance in Multiple Sclerosis After Immunization With DNA Encoding Myelin Basic Protein in a Randomized, Placebo-Controlled Phase 1/2 Trial
Archives of Neurology
‹
1
2
Related publications
Safety and Acceptability of Clozapine and Risperidone in Progressive Multiple Sclerosis: A Phase 1, Randomized, Blinded, Placebo-Controlled Trial
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
New England Journal of Medicine
Medicine
Etanercept in Alzheimer Disease: A Randomized, Placebo-Controlled, Double-Blind, Phase 2 Trial
Neurology
Neurology
A Phase 1b Randomized, Placebo-Controlled Clinical Trial With SNF472 in Hemodialysis Patients
British Journal of Clinical Pharmacology
Pharmacology
Structural Insight Into the Role of Myelin Basic Protein in Multiple Sclerosis
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
rhIGF-1/rhIGFBP-3 in Preterm Infants: A Phase 2 Randomized Controlled Trial
Yearbook of Paediatric Endocrinology
Autoantibodies to Myelin Basic Protein Catalyze Site-Specific Degradation of Their Antigen
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Patient-Reported Outcomes of Multiple Myeloma Patients Treated With Panobinostat After ≥2 Lines of Therapy Based on the International Phase 3, Randomized, Double-Blind, Placebo-Controlled PANORAMA-1 Trial
British Journal of Haematology
Hematology
Intraureteral Lidocaine for Ureteral Stent Symptoms Post-Ureteroscopy: A Randomized, Phase 2, Placebo-Controlled Trial
Canadian Urological Association Journal
Urology
